Article: OTHER NEWS TO NOTE.(industry briefs)

Angstrom Pharmaceuticals Inc., of San Diego, named Virgil Thompson its president and CEO. His more than 25 years of industry experience include leading early stage biopharmaceutical companies such as Cytel Corp., also of San Diego. Angstrom is developing inhibitors designed to interfere with the urokinase plasminogen activator system in patients suffering from conditions that are mediated through cell migration and invasion, angiogenesis and neovascularization.

Cell Therapeutics Inc., of Seattle, presented at the Chinese Society of Hematology conference in Shanghai data from clinical trials indicating that Trisenox (arsenic trioxide) may be effective in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!